3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Leukemia, Myeloid, Acute
23
Myelodysplastic Syndromes
14
Leukemia, Myelomonocytic, Chronic
7
Myeloproliferative Disorders
4
Myelodysplastic-Myeloproliferative Diseases
2
Leukemia, Biphenotypic, Acute
2
Anemia, Refractory, with Excess of Blasts
2
Triple Negative Breast Neoplasms
1
Thrombocythemia, Essential
1
Systemic Mastocytosis With an Associated Hematologic Neoplasm
1
Prostatic Neoplasms
1
Primary Myelofibrosis
1
Polycythemia Vera
1
Neurofibrosarcoma
1
Neuroendocrine Tumors
1
Mesothelioma, Malignant
1
Mesothelioma
1
Melanoma
1
Lymphoma, T-Cell, Peripheral
1
Lymphoma, Non-Hodgkin
1
Lymphoma, Large B-Cell, Diffuse
1
Lymphoma, B-Cell
1
Leukemia, Myeloid, Chronic-Phase
1
Hodgkin Disease
1
GATA2 Deficiency
1
Cytopenia
1
Central Nervous System Neoplasms
1
Carcinoma, Non-Small-Cell Lung
1
Carcinoma, Merkel Cell
1
BRCA1 Mutation
1
Interventions
Bevacizumab
120
Fluorouracil
90
Cetuximab
84
Leucovorin
82
Oxaliplatin
80
pembrolizumab
70
Irinotecan
66
Nivolumab
46
Capecitabine
43
Specimen Handling
40
regorafenib
30
Folfox protocol
29
trifluridine tipiracil drug combination
28
Magnetic Resonance Spectroscopy
27
Biopsy
27
Panitumumab
26
HMPL-013
26
Standard of Care
25
IFL protocol
21
Gemcitabine
20
Blood Specimen Collection
19
tislelizumab
18
atezolizumab
18
Trifluridine
18
Cisplatin
18
balstilimab
16
Colonoscopy
16
Carboplatin
16
encorafenib
15
Paclitaxel
14
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Colorectal Neoplasms
×
decitabine and cedazuridine drug combination
×
1 year
×
Clear all
No trials found.